Analysis of Factors Influencing Amyloid-beta Deposition in the Context of Alzheimer's Disease

As a neurodegenerative ailment, Alzheimer's disease closely associates with the deposition of beta-amyloid (A) proteins. The abnormal accumulation of A plays a pivotal role in the diseases progression, leading to cognitive impairment and neurological damage. APOE is a key gene that affects the accumulation of A, with its 2, 3, and 4 alleles closely associated with the likelihood and advancement of Alzheimer's disease. APOE2 variant appears to slow disease progression by reducing A deposition, thereby exerting a protective effect; whereas the APOE4 allele increases the risk of the disease by promoting A deposition and speeding up its advancement. Besides the APOE gene, variations in the TREM2 and Presenilin-1 (PSEN1) genes are also linked to the development of Alzheimer's disease. TREM2 plays a role in immune responses and inflammatory processes, and mutations in this gene may impair the brains ability to clear A , resulting in increasing deposition. Presenilin-1, a component of the gamma-secretase complex, plays a key role in producing A, and mutations in this gene are linked to the development of early-onset Alzheimer's disease. This paper examines genetic factors, epigenetics, chemical reactions, and cellular dysfunction from multiple dimensions to explore how they interact to affect the production, deposition, and pathogenic mechanisms of A. Through this multidimensional analysis, this study emphasizes the interplay of various factors in the pathological process of Alzheimer's disease, jointly promoting the abnormal accumulation of A. By unveiling these complex mechanisms, the study provides insights into potential targets for upcoming treatment plans.